The U.S. durable medical equipment market size was valued at USD 63.14 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.63% from 2024 to 2030. The market is majorly driven by the rising product demand due to the growing geriatric population that is susceptible to various chronic diseases. For instance, according to America’s Health Rankings 2023 annual report, approximately 43% of the U.S. population, totaling 133 million people, was suffering from one or more chronic illnesses in 2022. Moreover, in the same year, more than 29 million adults were reported to be suffering from three or more chronic conditions. These chronic conditions, including arthritis, asthma, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), cardiovascular disease, cancer, depression, and diabetes, collectively contribute to the rising need for hospitalization. Thus, due to the increasing prevalence of chronic diseases and the subsequent surge in hospitalizations, the demand for durable medical equipment is expected to grow, fueling growth in the U.S. market.
The COVID-19 pandemic has initially disrupted the market due to the lack of accessibility of the products to the customers. The pandemic has affected the operations and financial condition of various market players. The DME suppliers have encountered interruptions in the supply chain, such as significant delays and order cancellations, as a result of public health and economic emergencies related to the COVID-19 pandemic.
Furthermore, rising geriatric population is a significant factor propelling the growth of U.S. DME market. As the world's population ages, there is a subsequent increase in the demand for healthcare services and infrastructure to address the unique & evolving healthcare needs of older adults. According to America's Health Rankings 2022 data, nearly 58 million adults aged 65 and above presently reside in the U.S., constituting around 17.3% of the nation's population. Projections indicate that by 2040, this proportion is anticipated to grow to 22%. As the last of the baby boomer generation reaches older adulthood in 2030, estimations suggest that over 73.1 million older adults will be living in the U.S. The geriatric population is more prone to chronic health conditions, such as cardiovascular diseases, respiratory disorders, and orthopedic issues. Durable medical equipment’s such as wheelchair, canes and crutches play a vital role in facilitating the safe and efficient movement of elderly patients within facilities, supporting their treatment and care. Thus, due to the increasing geriatric population, the demand for durable medical equipment is expected to grow in the near future.
Furthermore, geriatric population often requires long-term care and assistance, leading to an increased demand for durable medical equipment, especially those designed for long-term care use. These durable medical equipment’s become integral in different settings such as home care, hospitals, including acute and chronic hospitals in different regions & states. Therefore, the growing geriatric population serves as a key factor fueling the growth of the market, necessitating the development and adoption of innovative & specialized equipment to meet the end use requirements of an aging demographic.
The market growth stage is moderate, and pace of the market growth is accelerating. The U.S. DME market is characterized by a moderate-to-high degree of growth. Key drivers include combination of technological advancements, aging demographics, and increasing prevalence of chronic diseases. The market is characterized by a diverse range of products, including mobility aids, respiratory equipment, and patient monitoring devices. Regulatory frameworks, such as Medicare reimbursement policies, significantly influence market dynamics, shaping the competitive landscape and market entry barriers.
In addition, U.S. DME market showcases a strong trend toward home healthcare solutions, emphasizing patient convenience and cost-effectiveness. Advances in materials and design contribute to durable and user-friendly equipment, while a focus on telehealth integration further propels the market forward. As the healthcare landscape evolves, U.S. DME market continues to adapt, offering innovative solutions that cater to the evolving needs of healthcare providers and patients alike. For instance, in January 2024, Robooter, a mobility device manufacturer specializing in robotic technology for the elderly and disabled, introduced its innovative power wheelchair X40 at the Consumer Electronics Show (CES) 2024 in Las Vegas. The company expanded its product range with the launch of the E Series in 2023, emphasizing adaptability for both indoor and outdoor use. This strategic move caters to the diverse needs of elders and individuals with disabilities. Robooter's focus on the U.S. market is evident through its active efforts to strengthen partnerships with local collaborators. Participation in CES, alongside esteemed American collaborators, underscores the company's dedication to expanding its presence and advancing accessibility solutions in the U.S. market. The impact of Robooter's technological advancements is poised to contribute significantly to the evolution of mobility solutions within the industry.
The market is marked by a significant degree of innovation, propelled by rapid technological advancements and a heightened adoption of advanced products, especially in home care settings. This innovation surge is fueled by a growing demand for home care services, driving the development and integration of cutting-edge technologies such as artificial intelligence, big data analytics, and remote monitoring within the DME sector. Companies heavily investing in these technological advancements gain a competitive edge, contributing to the market's overall growth and reflecting a dynamic landscape that continually meets evolving healthcare needs through innovation.
Regulations play a pivotal role in shaping themarket. Stringent regulatory frameworks, particularly related to reimbursement policies such as those governed by Medicare, significantly influence market dynamics. Compliance with these regulations poses challenges but is crucial for market entry. The regulatory environment fosters a standardized approach, ensuring the safety and efficacy of DME. It also acts as a key determinant in the competitive landscape, affecting product development and market access for companies operating in the U.S. DME sector. Overall, regulations have a profound impact, guiding industry practices and contributing to the market's stability and credibility.
The market is witnessing a notable level of merger and acquisition activities. Companies within the sector are strategically consolidating to enhance their market presence, broaden product portfolios, and achieve economies of scale. M&A transactions are driven by the pursuit of synergies, technological advancements, and the need for strategic partnerships to navigate evolving healthcare landscapes. This trend indicates a dynamic market where businesses are aligning resources to capitalize on growth opportunities and address challenges, ultimately influencing the competitive landscape and shaping the future trajectory of the U.S. DME market. For instance, in November 2023[KV3] Humana Inc., a health and well-being company, has partnered with national organizations Rotech Healthcare Inc. and AdaptHealth Corp. to provide DME services. This collaboration, set to commence on July 1 under a value-based structure which aims to enhance the health support for Humana Medicare Advantage HMO members in their homes. Each national DME provider will serve specific regions of the country, marking a strategic move in the evolving DME market.
The market is characterized by high fragmentation, with a multitude of players offering diverse products and services. This fragmentation results from the presence of numerous small and medium-sized companies, contributing to a competitive landscape where companies compete for market share. The diversity in product offerings and specialization among various players adds complexity to the market dynamics, making strategic collaborations and innovative approaches crucial for sustained growth and market penetration.
The market is experiencing notable regional expansion as companies strategically broaden their geographic footprint. This trend reflects a proactive approach to tap into diverse healthcare needs across different regions, capitalize on emerging opportunities, and establish a stronger market presence. Regional expansion allows DME providers to adapt their offerings to local requirements and regulations, fostering increased accessibility and enhancing their competitive position in the dynamic U.S. healthcare landscape.
The monitoring and therapeutic devices segment held the largest revenue share of over 89.31% in 2023 due to the increasing prevalence of chronic diseases requiring long-term care. In addition, increasing patient preference for at-home medical treatment or remote medical services over an in-patient setting is contributing to the segment growth. In monitoring and therapeutic devices, neuromonitoring techniques are expected to witness growth over the forecast period as they are becoming a part of standard medical practices and are routinely used during many surgical procedures.
The personal mobility devices segment is anticipated to register the fastest growth rate during the forecast period. The growing geriatric population and rising chronic illnesses are likely to create more need and demand for mobility products over the forecast period as these factors generally reduce the ability to move and perform physical tasks to maintain independent functioning. Moreover, aged people are more prone to falls, which can cause fatal or non-fatal injuries.
Hospitals segment dominated the market in 2023 driven by a surge in patients with rising chronic diseases in the country. Hospitals, equipped with advanced medical technology and skilled healthcare professionals, are the primary facilities for addressing these disorders. Moreover, hospitals are proactively initiating measures to manage damages resulting from accidental pullouts. For instance, in January 2022, Sanford Health announced the launch of its first-in-human clinical study of its device to reduce accidental catheter dislodgment. Thus, in turn is expected to drive the segment growth.
Home healthcare is expected to witness the highest growth rate over the forecast period due to the cost-saving approach for the patient to get remote healthcare services. The rising preference for home-based care aligns with a broader trend in the healthcare industry, emphasizing convenience, reduced healthcare costs, and the comfort of receiving medical services within the familiar environment of one's home. This surge in demand for durable medical equipment within the home healthcare setting reflects a transformative shift in patient care delivery. As the industry continues to adapt to these changing dynamics, U.S. durable medical equipment market stands ready to play a pivotal role in shaping the future landscape of patient-centric healthcare.
Key companies in the market are proactively driving industry evolution through strategic initiatives like mergers & acquisitions, regional expansion, and innovative product development. With a focus on capturing a substantial market share, these players introduce cutting-edge technologies and diversified products. The market landscape is characterized by a mix of major players, local distributors, and suppliers. The key emphasis is on providing cost-efficient products with remote usability. Notably, trends such as strategic home healthcare solutions, artificial intelligence integration, and expanded telehealth capabilities are pivotal, addressing evolving healthcare needs and propelling overall market growth. This dynamic landscape sets new industry standards, fosters healthy competition, and enhances the overall quality of products and services in the U.S. DME market.
The following are the leading companies in the U.S. durable medical equipment market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these U.S. durable medical equipment companies are analyzed to map the supply network.
In January 2024,Sunrise Medical has launched the Switch-It Vigo head control, a wireless and proportional alternative drive system designed for power wheelchairs. The system developed by Now Technologies LTD which joined Sunrise Medical in 2022. Vigo allows users to navigate their power wheelchairs and devices with subtle head movements. Its innovative technology has received acclaim in various markets and secured awards, including the 2023 Mobility Product Award in the "Alternative Driving Controls" category from Mobility Management publication. Vigo's addition complements Switch-It's range of advanced controls for power wheelchairs. This strategic move is anticipated to contribute to the increased adoption of U.S. Durable Medical Equipment in the near future.
In January 2024, Medline introduced the OptiView Transparent Dressing with HydroCore technology as the latest addition to its advanced wound care portfolio. The company aim is to enhance efficiency with tools like OptiView, addressing healing barriers and elevating care standards. Users have reported benefits such as improved treatment and prevention of pressure injuries, along with cost savings due to longer wear time and reduced dressing changes. Thus, due to such advancements, the market is expected to grow in the near future.
In October 2023, Home Care Delivered, Inc., successfully acquired Medline Industries, LP's DMEPOS supplier business unit. This strategic acquisition aims to boost HCD's market presence, expand its geographical reach, and broaden its customer base. The move reinforces relationships with patients, healthcare plans, providers, and manufacturers.This strategic move is anticipated to contribute to the increased adoption of U.S. Durable Medical Equipment in the near future.
In March 2023, GF Health Products, Inc. (Graham-Field) expanded its Sub-Acute Care and Extended Care Beds. The new beds utilize enhanced manufacturing resources, including computer-controlled laser welding, robotic assembly, and an upgraded automated coating line.
In January 2022, Medically Home secured a substantial $110 million funding round from strategic investors like Baxter International Inc., Global Medical Response (GMR), and Cardinal Health. With representation on the company's Board, these investors, alongside Cardinal Health, Mayo Clinic, and Kaiser Permanente, reaffirm their confidence in Medically Home's model. The model transforms patients' homes into safe alternative care sites, offering both high and lower acuity care. This funding underscores the growing expansion of the model nationwide. By enhancing health system capacity and resilience, while aligning with patient preferences for home-based care, Medically Home's approach reflects a significant industry shift. This innovative model is poised to impact the market, meeting evolving healthcare demands and ensuring patient-centric care.
Report Attribute |
Details |
Market size value in 2024 |
USD 66.81 billion |
Revenue forecast in 2030 |
USD 92.83 billion |
Growth rate |
CAGR of 5.63% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends, product outlook |
Segments covered |
Product, end-use |
Key companies profiled |
Invacare Corp.; Sunrise Medical; Arjo; Medline Industries, Inc.; GF Healthcare Products, Inc.; Carex Health Brands, Inc.; Cardinal Health; Drive DeVilbiss Healthcare; NOVA Medical Products; Kaye Products, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. durable medical equipment market report based on product, and end-use.
Product Outlook (Revenue, USD Million, 2018 - 2030)
Personal Mobility Devices
Wheelchairs
Electric Wheelchairs
Manual Wheelchairs
Scooters
Walker and Rollators
Canes and Crutches
Door Openers
Other Devices
Bathroom Safety Devices and Medical Furniture
Commodes and Toilets
Mattress & Bedding Devices
Monitoring and Therapeutic Devices
Blood Glucose Monitors
Continuous Passive Motion (CPM)
Infusion Pumps
Nebulizers
Oxygen Equipment
Continuous Positive Airway Pressure (CPAP)
Suction Pumps
Traction Equipment
Others Equipment
Insulin Pumps
Ostomy Bags & Accessories
Wound Care Products
Cardiology Devices
Vital Signs Monitor
Respiratory Supplies
Urinary Supplies
Diabetic Supplies
Incontinence Products
Orthopedic Braces & Support
Muscle Stimulators
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Home Healthcare
Others
b. The U.S. durable medical equipment market size was established at USD 63.14 billion in 2023 and is expected to reach USD 66.81 billion in 2024.
b. The U.S. durable medical equipment market is expected to grow at a compound annual growth rate of 5.63% from 2024 to 2030 to reach USD 92.83 billion by 2030.
b. The monitoring and therapeutic devices segment dominated the U.S. durable medical equipment market with a share of 89.31% in 2023. This is attributable to their ease of use, convenience, and patient preference for the equipment.
b. Some key players operating in the U.S. DME market include Invacare Corporation; Sunrise Medical; ArjoHuntleigh; Hill-Rom; Stryker; Medline Industries, Inc.; Medical Device Depot, Inc.; GF Health Products Inc.; Carex Health Brands; Baxter International, Inc.; Becton, Dickinson and Company; and Joerns Healthcare LLC.
b. Key factors that are driving the U.S. durable medical equipment market growth include an increase in the prevalence of chronic disease, rapid technological advancements, and a rising aging population.
Table of Contents
Chapter 1. U.S. Durable Medical Equipment Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. U.S. Durable Medical Equipment Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Durable Medical Equipment Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Regulatory Scenario
3.3. Reimbursement Scenario
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing prevalence of chronic diseases requiring long-term care
3.4.1.2. Rapidly growing geriatric population
3.4.1.3. Technological advancements
3.4.2. Market Restraint Analysis
3.4.2.1. High purchase and maintenance costs
3.4.2.2. Lack of skilled professionals to handle this equipment
3.4.3. Market Opportunity Analysis
3.4.3.1. Increasing penetration of home healthcare services and staff
3.4.3.2. Merger and acquisitions
3.4.4. Market Challenge Analysis
3.4.4.1. Product recall
3.4.4.2. Rising competition
3.5. DME Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Bargaining power of suppliers
3.5.1.2. Bargaining power of buyers
3.5.1.3. Threat of substitutes
3.5.1.4. Threat of new entrants
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political & Legal Landscape
3.5.2.2. Economic and Social Landscape
3.5.2.3. Technological landscape
3.5.3. COVID-19 Impact Analysis
3.5.3.1. Disrupted DME
3.5.3.2. Obstacles in DME
Chapter 4. DME Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. DME Market: Product Movement Analysis & Market Share, 2023 & 2030
4.3. Personal Mobility Devices
4.3.1. Personal Mobility Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Wheelchairs Market
4.3.2.1 Wheelchairs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.2 Electric Wheelchairs Market
4.3.2.2.1 Electric Wheelchairs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.3 Manual Wheelchairs Market
4.3.2.3.1 Manual Wheelchairs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Scooters Market
4.3.3.1 Scooters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Walker and Rollators Market
4.3.4.1 Walker and Rollators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Canes and Crutches Market
4.3.5.1 Canes and Crutches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Door Openers Market
4.3.6.1 Door Openers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.7. Other Devices Market
4.3.7.1 Other Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Bathroom Safety Devices and Medical Furniture
4.4.1. Bathroom Safety Devices and Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Commodes and Toilets Market
4.4.2.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Mattress & Bedding Devices Market
4.4.3.1 Mattress & Bedding Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Monitoring and Therapeutic Devices
4.5.1. Monitoring and Therapeutic Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Blood Sugar Monitors Market
4.5.2.1 Blood Sugar Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Continuous Passive Motion (CPM) Market
4.5.3.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Infusion Pumps Market
4.5.4.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Nebulizers Market
4.5.5.1 Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.6. Infusion Pumps Market
4.5.6.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.7. Oxygen Equipment Market
4.5.7.1 Oxygen Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.8. Continuous Positive Airway Pressure (CPAP) Market
4.5.8.1 Continuous Positive Airway Pressure (CPAP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.9. Suction pumps Market
4.5.9.1 Suction Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.10. Traction equipment Market
4.5.10.1 Traction Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11. Others Market
4.5.11.1 Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.2 Insulin Pumps Market
4.5.11.2.1 Insulin Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.3 Ostomy Bags & Accessories Market
4.5.11.3.1 Ostomy Bags & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.4 Wound Care Products Market
4.5.11.4.1 Wound Care Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.5 Cardiology Devices Market
4.5.11.5.1 Cardiology Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.6 Vital Signs Monitor Market
4.5.11.6.1 Vital Signs Monitor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.7 Respiratory Supplies Market
4.5.11.7.1 Respiratory Supplies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.8 Urinary Supplies Market
4.5.11.8.1 Urinary Supplies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.9 Diabetic Supplies Market
4.5.11.9.1 Diabetic Supplies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.10 Incontinence Products Market
4.5.11.10.1 Incontinence Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.11 Orthopedic Braces & Support Market
4.5.11.11.1 Orthopedic Braces & Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.12 Muscle Stimulators Market
4.5.11.12.1 Muscle Stimulators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.11.13 Others Market
4.5.11.13.1 Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. DME Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. DME Market: End Use Movement Analysis & Market Share, 2023 & 2030
5.3. Hospitals
5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Specialty Clinics
5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgical Centers
5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Diagnostic Centers
5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Home Healthcare
5.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Other End Use
5.8.1. Other End Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Market Participant Categorization
6.2. Key Company Profiles
6.2.1. Invacare Corporation
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. ArjoHuntleigh
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Stryker Corporation
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. Hill Rom, Inc.
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. Drive Medical
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. GF Health Products, Inc.
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. Sunrise Medical
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Medline Industries
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Hill Rom, Inc.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives
6.2.10. Carex Health Brands, Inc
6.2.10.1. Company Overview
6.2.10.2. Financial Performance
6.2.10.3. Product Benchmarking
6.2.10.4. Strategic Initiatives
6.2.11. Becton, Dickinson and Company
6.2.11.1. Company Overview
6.2.11.2. Financial Performance
6.2.11.3. Product Benchmarking
6.2.11.4. Strategic Initiatives
6.2.12. General Electric Company
6.2.12.1. Company Overview
6.2.12.2. Financial Performance
6.2.12.3. Product Benchmarking
6.2.12.4. Strategic Initiatives
6.2.13. Medtronic PLC
6.2.13.1. Company Overview
6.2.13.2. Financial Performance
6.2.13.3. Product Benchmarking
6.2.13.4. Strategic Initiatives
6.2.14. Compass Health Brands
6.2.14.1. Company Overview
6.2.14.2. Financial Performance
6.2.14.3. Product Benchmarking
6.2.14.4. Strategic Initiatives
6.2.15. Getinge AB
6.2.15.1. Company Overview
6.2.15.2. Financial Performance
6.2.15.3. Service Benchmarking
6.2.15.4. Strategic Initiatives
6.2.16. Resmed Inc.
6.2.16.1. Company Overview
6.2.16.2. Financial Performance
6.2.16.3. Product Benchmarking
6.2.16.4. Strategic Initiatives
6.3. Heat Map Analysis/ Company Market Position Analysis
6.4. Estimated Company Market Share Analysis, 2022
6.5. List of Other Key Market Players
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 US DME Market, by Product, 2018 - 2030, (USD Million)
Table 4 US DME Market, by End Use, 2018 - 2030 (USD Million)
Table 5 Participant’s Overview
Table 6 Financial Performance
Table 7 Service Benchmarking
Table 8 Strategic Initiatives
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 DME Market, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Country Marketplace: Key Takeaways
Fig. 13 U.S. DME Market, 2018 - 2030 (USD Million)
Market Segmentation
Every year, cancer, neurological conditions, gynecological, ophthalmic, and cardiac disorders are becoming more prevalent. The treatment of these disorders may require surgical procedures, which increases the demand for surgical intervention, thus resulting in requirement of long-term care until recovery. For instance, the prevalence of cancer is rising, as per statistics published by the WHO. Approximately 8.2 million people die every year from cancer, which accounts for 13.0% of deaths worldwide. Moreover, there is anticipated to be a 70.0% increase in new cancer cases over the next couple of decades. In addition, over 100 types of cancers exist, which require unique therapy and postoperative recovery. Occasionally, a post-surgery patient is immobile for several days. In such cases, DME forms a key component in long-term recovery, offering convenience and support.
Growing healthcare expenditure is a crucial concern, and private players and the government constantly strive to curb these costs. With an ever-increasing prevalence of diseases and a baby boomer population, healthcare expenditure levels are expected to continue to grow during the forecast period. The growth of home healthcare as a cost-effective alternative to hospital stays is expected to serve this market as a key driver over the forecast period. The graph below highlights the cost-effectiveness associated with home healthcare establishments. Moreover, this is favored by payers as they aim for cost-effective services while receiving quality healthcare services.
Durable medical equipment is essential for people with disability to assist them with daily activities and help them participate in the community. It is one of the basic needs of mobility disabled people. However, mobility equipment costs are high and account for a majority of government and household expenses. With technological advancements in devices, their cost is also rising. Walking aids such as rollators and walkers incur servicing and maintenance costs as they are motorized and have braking systems. Increasing costs of durable medical equipment are expected to restrain the market growth. However, several government initiatives and insurance schemes are expected to help overcome this limitation.
This section will provide insights into the contents included in this U.S. durable medical equipment market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
Company overview
Financial performance
Product benchmarking
Latest strategic developments
Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance
A three-pronged approach was followed for deducing the U.S. durable medical equipment market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for U.S. durable medical equipment market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of U.S. durable medical equipment market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The U.S. durable medical equipment market was categorized into two segments, namely product (Personal Mobility Devices, Bathroom Safety Devices and Medical Furniture, Monitoring and Therapeutic Devices), and end-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Home Healthcare).
The U.S. durable medical equipment market was segmented into product, and end-use. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The U.S. durable medical equipment market was analyzed at a regional level. These region are further divided into one country, namely, the U.S.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The U.S. durable medical equipment market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Invacare Corp. - Invacare was established in 1885 and headquartered in the U.S. The company employs 3,400 people across the globe. Invacare Corporation has core competencies in long-term and home-care medical products. It distributes and manufactures nonacute medical equipment and respiratory products. It has a distribution network in 80 locations worldwide. Various acquisitions and product development initiatives have helped the company boost its market share. The company has gained popularity by introducing innovative products such as motorized wheelchairs with computerized controls.
Sunrise Medical - The company was founded in 1978 in the UK. Sunrise Medical develops, designs, and distributes customized and standard positioning and seating systems, mobility aids, mobility scooters, powered wheelchairs, and manual wheelchairs. The company has production facilities in China, Poland, the Netherlands, the U.S., Germany, Mexico, and the UK. Its essential products are marketed under proprietary Lomax, Coopers, JAY, Sterling, Breezy, Zippie, and QUICKIE brands. Its products are sold through a network of homecare medical product distributors or dealers in more than 130 countries.
ArjoHuntleigh - The company is based in Sweden and formed in 1957. ArjoHuntleigh employs more than 6,000 employees. Arjo is a subsidiary of Getinge Group, a Swedish medical technology company founded in 1904. It is involved in the extended patient care devices segment. The company offers products across various segments, including patient transfer solutions, therapeutic support systems, medical beds, hygiene systems, vascular therapy, disinfectant products, clinical couches, & diagnostic products. Moreover, the company also offers assessment services, rentals, technical services, and architectural services.
Medline Industries, Inc. - Medline Industries was established in 1966 and headquartered in the U.S. The company has a worldwide employee strength of more than 28,000. Medline Industries, Inc. supplies and manufactures healthcare products. The company has 42 distribution centers across North America, with 550,000 products in its portfolio, including exam gloves, durable medical equipment, incontinence products, surgical procedure tray kits, and drapes & gowns. The company operates in more than 90 countries and across 43 U.S. distribution centers. It also provides business solutions in quality management, staff management, recruitment, readmissions, and capital planning & services.
GF Healthcare Products, Inc. - GF Healthcare Products, Inc. is a leader in medical product manufacturing. The company was established in 1946 in the U.S. Some of its brands are Lumiscope Consumer Diagnostics, Intensa Medical and Laboratory Furniture, Grafco Medical-Surgical Products, Labtron Diagnostic Equipment, John Bunn Respiratory Products, Hausted Surgical Stretchers & Chairs, Basic American Medical Products Beds & Furnishings, Lumex Patient Aids & Healthcare Seating, and Everest & Jennings Wheelchair. Its manufacturing sites are located in various states of the U.S.
Carex Health Brands, Inc. - Carex Health Brands, Inc. is one of the leaders in self-care and at-home medical products. The company provides services to regional, national, and independent drug, food, mass retailers, medical dealers, distributors, and wholesalers. The company's product portfolio includes bathroom safety, mobility, personal care, medication organizers, enablers and aids for daily living, pain management, bright light therapy products, self-care products, and at-home care and patient room equipment. The company is a wholly-owned subsidiary of Compass Health Brands.
Joerns Healthcare, LLC - Joerns Healthcare, LLC was established in the US in the year 1889 and provides healthcare equipment and services. The Company offers bed frames, respiratory, mattresses, lifts, and durable medical equipment and is a premier supplier and service provider in post-acute care. Joerns Healthcare has a nationwide network of service centers and a service fleet with over 130 sites.
Stryker - Stryker was formed in 1941 and employs around 46000 employees. The company offers products and services related to medical, surgical, orthopedics, spine, and neurotechnology fields. Its product offerings include patient handling equipment, Emergency Medical Services (EMS) & evacuation equipment; powered surgical instruments & joint replacement solutions, trauma products; micro & spine implant systems: orthobiologics & endoscopic products; and surgical navigation systems. The company has a presence across more than 100 countries around the world.
Baxter International, Inc - Baxter International, Inc. offers a broad portfolio of sterile intravenous solutions, acute and chronic dialysis therapies, parenteral nutrition therapies, infusion systems and devices, generic injectable pharmaceuticals, inhaled anesthetics, and surgical hemostat and sealant products. In addition, the company serves customers in more than 100 countries located on major continents like North America, Europe, APAC, Latin America, and MEA. Its primary customers are hospitals, nursing homes, kidney dialysis, and rehabilitation centers.
Becton Dickinson - Becton Dickinson was established in 1897 in the U.S. The company accommodates around 65,000 employees globally. BD is a leading medical technology company that specializes in Medical Devices, Biosciences, Medical Supplies, Laboratory Instruments, Reagents, Diagnostics Products, Antibodies, Surgical and Vascular Access.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
revenue/volume
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2019 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."